Akathisia can occur when consumers start, stop or change a dose of certain medications. Given that some consumers skip medication due to high drug prices, it is good to see lawmakers address drug pricing issues.

For more information, click here.

Many drugs, to include over-the-counter drugs, can have adverse effects that aren’t always communicated. Make sure to discuss possible adverse effects with your doctor. This includes adverse effects related to bleeding when taking SSRIs and NSAIDs.

For more info, click here.

The New York Times poses interesting questions about generic drugs. For more info, click here.

It’s great to see this akathisia info and helpful tips on how to improve emotional wellness. For more info, click here.

The Food and Drug Administration has announced the labels for several sleep drugs must now list additional adverse effects to include risky behaviors such as sleepwalking and sleep driving, that can lead to injury and even death.

For more info, click here.

Dr. Barnhorst’s interesting opinion piece for the New York Times can spark important conversations.

To read the article, click here.

Let’s make this year’s fundraising gala the biggest ever and enjoy the sites in the “windy city.”

A British report finds 56% of people who try to come off drugs marketed as antidepressants suffer withdrawal effects, and 46% of those having withdrawal effects describe them as severe. Withdrawal effects include suicidality, dizziness and agitation, all of which can also be signs of withdrawal akathisia. To learn more about withdrawal akathisia, take Akathisia 101 at MISSD.LearnUpon.com

For more info about this drug withdrawal study, click here.

Dolin’s attorneys are asking the high court to toss out the decision of the U.S. Seventh Circuit Court of Appeals which overturned the Chicago jury’s verdict that determined Paxil maker, GSK, was liable for Stewart Dolin’s suffering and death.

To see the full article, click here.

The New Yorker has an informative article regarding the adverse withdrawal effects many consumers experience when trying to discontinue psych drugs. MISSD is pleased to see this important topic gaining public attention.

To read the full article, click here.